Evofem Biosciences Inc. buy krebskrebs
Start price
22.03.21
/
50%
€34.73
Target price
22.03.22
€52.50
Performance (%)
-84.26%
End price
23.03.22
€5.47
Summary
This prediction ended on 23.03.22 with a price of €5.47. The BUY prediction by krebskrebs for Evofem Biosciences Inc. performed very badly with a performance of -84.26%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Evofem Biosciences Inc. | - | - | - | - |
| iShares Core DAX® | -1,74 % | 5,67 % | 7,84 % | 50,71 % |
| iShares Nasdaq 100 | 2,81 % | 11,55 % | 36,61 % | 102,82 % |
| iShares Nikkei 225® | -0,11 % | 9,65 % | 45,65 % | 64,80 % |
| iShares S&P 500 | 0,97 % | 7,24 % | 26,97 % | 70,25 % |
Comments by krebskrebs for this prediction
In the thread Evofem Biosciences diskutieren
In the thread Trading Evofem Biosciences
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten